Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (301-310 of 423) with videos related to

Pageof 43
Sort By:
Psychopharmacology Bulletin|January 18, 2011
Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot studyZuowei Wang, Keming Gao, David E Kemp, et al.
Journal of Child and Adolescent Psychopharmacology|August 1, 2017
A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar DisorderRobert L Findling, Eric A Youngstrom, Brieana M Rowles, et al.
Journal of Affective Disorders|April 3, 2012
Pediatric bipolar disorder and ADHD: family history comparison in the LAMS clinical sampleL Eugene Arnold, Katherine Mount, Thomas Frazier, et al.
Journal of Child and Adolescent Psychopharmacology|March 21, 2013
Post-acute effectiveness of lithium in pediatric bipolar I disorderRobert L Findling, Vivian Kafantaris, Mani Pavuluri, et al.
Clinical Therapeutics|March 22, 2021
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled TrialAzmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2007
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorderRobert L Findling, Elizabeth J Short, Nora K McNamara, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 24, 2006
Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilizationRobert L Findling, Nora K McNamara, Robert Stansbrey, et al.
Bipolar Disorders|February 27, 2013
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled studyRobert L Findling, Christoph U Correll, Margaretta Nyilas, et al.
Journal of Child and Adolescent Psychopharmacology|February 10, 2016
Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?Mary A Fristad, Hannah Wolfson, Guillermo Perez Algorta, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot studyJohn H Heiligenstein, Sharon L Hoog, Karen Dineen Wagner, et al.
Pageof 43

Showing results (301-310 of 423) with videos related to

Sort By:
Pageof 43
Psychopharmacology Bulletin|January 18, 2011
Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot studyZuowei Wang, Keming Gao, David E Kemp, et al.
Journal of Child and Adolescent Psychopharmacology|August 1, 2017
A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar DisorderRobert L Findling, Eric A Youngstrom, Brieana M Rowles, et al.
Journal of Affective Disorders|April 3, 2012
Pediatric bipolar disorder and ADHD: family history comparison in the LAMS clinical sampleL Eugene Arnold, Katherine Mount, Thomas Frazier, et al.
Journal of Child and Adolescent Psychopharmacology|March 21, 2013
Post-acute effectiveness of lithium in pediatric bipolar I disorderRobert L Findling, Vivian Kafantaris, Mani Pavuluri, et al.
Clinical Therapeutics|March 22, 2021
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled TrialAzmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2007
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorderRobert L Findling, Elizabeth J Short, Nora K McNamara, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 24, 2006
Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilizationRobert L Findling, Nora K McNamara, Robert Stansbrey, et al.
Bipolar Disorders|February 27, 2013
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled studyRobert L Findling, Christoph U Correll, Margaretta Nyilas, et al.
Journal of Child and Adolescent Psychopharmacology|February 10, 2016
Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?Mary A Fristad, Hannah Wolfson, Guillermo Perez Algorta, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot studyJohn H Heiligenstein, Sharon L Hoog, Karen Dineen Wagner, et al.
Pageof 43